SCHEMBL5462425

SCHEMBL5462425

COc1ccc(C)cc1NC(=O)Nc1ccc(N2CCN(C(=O)Nc3ccc(N(C)C)cc3C(F)(F)F)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 5/20 0.47
MAPT P10636 7/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
TP53 P04637 3/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46
HTR1A P08908 2/20 0.46
HTR1D P28221 2/20 0.46
HTR1B P28222 2/20 0.46
HTR2A P28223 2/20 0.46
HTR2C P28335 1/20 0.46
HTR6 P50406 1/20 0.46
ALDH1A1 P00352 2/20 0.45
LMNA P02545 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
USP2 O75604 1/20 0.45
POLB P06746 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5465594 0.89 RBP4 (0.48) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5456051 0.85 MAPT (0.49) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5484266 0.81 MAPT (0.58) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5466060 0.80 MAPT (0.46) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5464801 0.80 MAPT (0.68) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5471132 0.80 RBP4 (0.47) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5455975 0.80 MAPT (0.58) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5462082 0.78 MAPT (0.52) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5453431 0.78 RBP4 (0.54) RBP4MAPTMEN1KMT2ATP53
SCHEMBL5456010 0.78 MAPT (0.51) RBP4MAPTMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 RBP4 2001/4885MAPT 758/4885MEN1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.